In fiscal year 2025, Moderna's revenue by segment (products & services) are as follows:
Learn more about Moderna’s Revenue by Geography
Check out competitors to Moderna in a side-by-side comparison.
Explore additional financial metrics for Moderna.
| Messenger RNA (mRNA) Medicines | 6848000000 |
|---|
| Collaboration Arrangement | 12000000 |
|---|---|
| Grant | 37000000 |
| Product Sales | 4517000000 |
| Product Sales | 3304000000 |
|---|
The above chart shows Moderna's revenue percentage share by segment (products and services).
In fiscal year 2023, Moderna's revenue by segment is as follows:
The above chart shows Moderna's revenue percentage share by segment (products and services).
In fiscal year 2024, Moderna's revenue by segment is as follows:
The above chart shows Moderna's revenue percentage share by segment (products and services).
In fiscal year 2025, Moderna's revenue by segment is as follows:
| Products & Services (Percent Share) | 2023 | 2024 | 2025 |
|---|---|---|---|
| Messenger RNA (mRNA) Medicines | 100% | - | - |
| Collaboration Arrangement | - | 0.26% | - |
| Grant | - | 0.81% | - |
| Product Sales | - | 98.93% | 100% |
| Total Revenue | 100% | 100% | 100% |
The above chart shows the revenue trend of different segments of Moderna.
In fiscal year 2025, the Product Sales generated the most revenue ($3.30 B), and the Product Sales generated the least revenue ($3.30 B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.